Latest filing published 15 Sept 2026 for UNITED THERAPEUTICS Corp, €12k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nilda Mesa (board member) discloses dealings in UNITED THERAPEUTICS Corp to SEC (Form 4). We count 22 filings; the first trade dates from 26 June 2021 and the latest from 14 September 2026.
No open-market purchase appears, only 13 sales worth €1.2M. Other entries cover 9 option exercises. Since January 2026: no purchases and 2 sales on the market.
The latest filing, published on 15 September 2026, reports an option exercise of €12k in UNITED THERAPEUTICS Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations